SPOTLIGHT: Draxis inks J&J deal

Contract manufacturer Draxis Pharma has just inked a new deal with Johnson & Johnson to make a variety of products through 2013. The contract includes a two-year ramp-up period and five years of commercial production estimated at $120 million. The deal will mean up to 100 new jobs for Draxis in the Montreal area, including 50 new workers at a brand-new facility. Release